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Abstract: Microcystins are acute hepatotoxins of increasing global concern in drinking and
recreational waters and are a major health risk to humans and animals. Produced by cyanobacteria,
microcystins inhibit serine/threonine protein phosphatase 1 (PP1). A cost-effective PP1 assay
using p-nitrophenyl phosphate was developed to quickly assess water and rumen content samples.
Significant inhibition was determined via a linear model, which compared increasing volumes of
sample to the log-transformed ratio of the exposed rate over the control rate of PP1 activity. To test the
usefulness of this model in diagnostic case investigations, samples from two veterinary cases were
tested. In August 2013 fifteen cattle died around two ponds in Kentucky. While one pond and three
tested rumen contents had significant PP1 inhibition and detectable levels of microcystin-LR, the
other pond did not. In August 2013, a dog became fatally ill after swimming in Clear Lake, California.
Lake water samples collected one and four weeks after the dog presented with clinical signs inhibited
PP1 activity. Subsequent analysis using liquid chromatography-mass spectrometry (LC-MS/MS)
detected microcystin congeners -LR, -LA, -RR and -LF but not -YR. These diagnostic investigations
illustrate the advantages of using functional assays in combination with LC-MS/MS.
Keywords: blue-green algae; cyanobacteria; diagnosis; microcystins; protein phosphatase inhibition
assay; veterinary toxicology

1. Introduction
Large blooms of cyanobacteria (also known as blue-green algae) can release a variety of toxic
metabolites, known as cyanotoxins [1]. Blooms are triggered by warm temperatures and high levels
of nitrogen and phosphorus from urban effluent and agricultural run-off [1]. The acute hepatotoxic
microcystins (MCs) are well known cyanotoxins. MC-LR (named for leucine and arginine at the two
variable amino acids in this cyclic heptapeptide) was the first identified MC to be associated with
toxicity and is therefore the most tested for and studied MC. Since then over 90 MC variants have
been identified [2]. Acute MC exposure can result in dermatitis, gastrointestinal upset and liver failure
and even death after high dose exposures [3]. Currently there are no legally enforceable US federal
regulations for cyanobacteria or cyanotoxins in drinking water, recreational waters, or in cyanobacteria
supplement products.
In response to continued increases in harmful cyanobacterial blooms in the United States the US
Environmental Protection Agency (USEPA) added cyanobacteria and cyanotoxins to the Candidate
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Contaminant List of unregulated contaminants [4]. In addition, the USEPA issued Health Advisories
for MC-LR in drinking water in June 2015 [4]. The World Health Organization has a recommended
maximum level of 1 µg/L of MC-LR (free and cell bound) in drinking water for humans [5], which was
based on the results of an acute hepatotoxicity with MC-LR in mice [6]. This provisional guideline does
not take into account species differences, more hydrophobic congeners, chronic exposure risk, or target
organs other than the liver. In veterinary medicine there is a particular concern for livestock [3,7–9],
canine [10–15] and wildlife exposure to cyanotoxins via surface drinking water from contaminated
ponds, lakes and rivers. As these species are typically exposed to environmental contaminants before
humans, they may act as sentinels of human health risk. The availability of rapid and low cost assays
is therefore essential to evaluate the risk of contaminated drinking water to livestock and companion
animals and to guide diagnostic investigations of cyanotoxin exposures.
To confirm MC toxicosis in animals, clinical signs and/or post mortem lesions must be compatible
with the analytical confirmation of MCs in biological samples. In tissues, MCs covalently bind
serine/threonine protein phosphatases (PP) 1 and 2A [16–18]; therefore extraction of free and bound
MCs from biological samples for high performance liquid chromatography (HPLC) or enzyme linked
immunosorbent assays (ELISA) is costly, challenging, and may lead to false negative findings or
underestimation of the true MC concentrations. As a result, most diagnostic testing relies heavily on
identifying the presence of MCs in water samples. When using only HPLC or ELISA techniques to
detect specific MC variant concentrations, the toxic potency of an environmental sample based on all
congeners present cannot be directly determined for two key reasons: (1) with MC cross-reactivity,
ELISAs may detect high concentrations of non-toxic MCs while having potentially low specificity
for highly toxic variants [19] and (2) analytical techniques relying on liquid chromatography-mass
spectrometry (LC-MS/MS) are limited by the availability of certified reference standards. Currently
only a small number of the over 90 MC congeners are available to be included in LC-MS/MS screening
assays. However, compared to ELISAs, LC-MS/MS has the benefit of being able to quantify a particular
MC congener. The aforementioned diagnostic tools are not capable of determining if the detected MCs
are functional (able to inhibit PPs). Therefore, to minimize the limitations of LC-MS/MS and ELISA
techniques and to fully assess the toxic potential of all congeners in a sample, biological activity assays
should be used in combination with LC-MS/MS and/or ELISA [20].
Protein phosphatase inhibition assays (PPIAs) were originally developed to study MC’s ability
to bind PP1 and 2A [21,22]. They are ideal biological toxicity assays for environmental samples.
PPIAs have become a standard method for MC detection with the use of the colorimetric substrate
p-nitrophenyl phosphate (pNPP, no color) and purified PP1 [19,23]. The assay measures the rate
of formation of p-nitrophenol (pNP, yellow color) by PPs over time and takes into account all
PP inhibitors present in a sample. The colorimetric PPIA has been optimized for MC detection
in cyanobacteria extracts using 96-well plates, and has shown acceptable correlation with HPLC
data [20,24,25]. With commercially available pNPP and purified PP1, which is significantly cheaper
than PP2A, the assay is very attractive to quickly and effectively screen for the presence of PP1
inhibitors. Currently, PPIAs are not common in veterinary diagnostic investigations. However, they
have the potential to detect the presence of toxins that may escape detection with LC-MS/MS or ELISA.
Therefore, the objectives of this study were (1) to standardize the PPIA using pNPP and purified PP1
after exposure to MC-LR and MC-LF, as hydrophilic and hydrophobic MC variant representatives,
(2) to use tautomycin and okadaic acid to validate the PPIA for toxins with varying PP1 inhibitory
constants (Ki ) (PP1 Ki = 0.04, 0.33 and 118 µg/L for MC-LR, okadaic acid and tautomycin, respectively),
(3) to apply a new statistical approach that takes into account the non-normal distribution of error of
PPIA data in order to further establish the PPIA as a robust and simple tool and (4) to apply the PPIA
assay to diagnostic investigations of canine and bovine microcystin toxicoses and compare the data to
LC-MS/MS data (analytical reference standards included were MC-LR, MC-LF, MC-RR, MC-YR and
MC-LA).
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2. Results and Discussion
2.1. Statistical Evaluation of the PPIA with Environmental Samples and Presentation of Data
Typically, PPIA data are presented as the percent PP activity (y-axis) after exposure to a range of
toxin concentrations (x-axis). In this study, however, the PPIA results are analyzed and the data are
presented differently. In an effort to determine whether minimal sample preparation of environmental
samples would provide a useful approach, we began by only sonicating and centrifuging samples
to initiate cell lysis and remove cellular debris. This is reflected by the x-axis, which represents the
volume of the centrifuged environmental sample analyzed. The use of this approach is based on the
assumption that a greater volume of environmental sample added to the assay equates to a higher
amount of toxin available to inhibit PP1. Final concentrations of PP1 and pNPP and total volume
in a given well remained constant. We assessed four different volumes of environmental samples.
The relative change in PP1 activity (y-axis) was determined using a linear regression model with
transformed data to account for the non-normal distribution of error of our data. Traditional statistical
methods used to analyze the change in PP activity as a percent of control rely on a one-way analysis of
variance with a post-hoc test to determine if individual samples significantly decreased PP activity.
This approach was not appropriate for our analysis due to (1) the non-normal distribution of our
data and (2) the requirement to compare PP activities of environmental samples to each other for the
one-way analysis of variance with a post hoc test; our goal was to determine whether a trend could
be identified across all volumes of environmental sample tested. To accomplish this, the rate of PP1
activity (mM pNP produced/ng PP1/minute) after exposure to a certain volume of environmental
sample was compared to the control PP1 activity (without sample exposure). By assigning the response
variable as a relative PP1 activity rate, expressed as log (exposed PP1 activity rate/control PP1 activity
rate), we were able to analyze a percent change in a continuous measurement (PP1 activity) with
normal error without requiring further transformation. By using this new approach to transform
PPIA data that takes into account the non-normal distribution of error, an appropriate application of
the linear regression model can now be used to quickly determine whether the slope of the model is
significant. In summary, data are presented as the relative change in PP1 activity (y-axis) to increasing
volumes of environmental sample (x-axis), resulting in a statistically sound qualitative assessment of
the presence of toxic PP1 inhibitors in diagnostic investigation samples.
2.2. Optimization of the PPIA
To optimize the PPIA the same approach and statistical method discussed above were used with
four known concentrations of MC-LR, MC-LF, tautomycin and okadaic acid. Initial buffer conditions
were based on previously published PPIAs [26,27] and a precipitation was formed after ten minutes,
reducing assay function. This effect has been observed before [28] and it was determined that a high
concentration of dithiothreitol (DTT) was the main cause for precipitation in our study as well as in
the previously published paper. By reducing chemical concentrations to those listed in “Experimental
Section 3.4”, buffers remained clear for the duration of the experiment (90 min). To determine the
optimal PPIA conditions using PP1 and pNPP, a range of 0.001–1 U/mL PP1 and 1–500 mM pNPP
was tested.
As previous PPIA work has shown [27], higher concentrations of PP1 and substrate result in
a steeper activity slope over time, likely because high concentrations of enzyme and substrate may
produce saturating amounts of detectable product and mask PP1 inhibition caused by low toxin
concentrations. Our goal was to use a linear model to determine whether samples contained PP1
inhibitors at moderate to low concentrations. We used 0.5 U/mL PP1 and 100 mM pNPP final
concentrations, resulting in 20%–80% inhibition of PP1 activity with 0.125–1 µg/L MC-LR and MC-LF,
1.6–13 µg/L tautomycin and 100–500 µg/L okadaic acid. All samples had a coefficient of variation
(standard deviation/mean in percent) below 15%, as is desirable for PPIAs [27].
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Table 1. Protein phosphatase 1 (PP1) activity after exposure to methanol (sample preparation control),
microcystin-LR (MC-LR), microcystin-LF (MC-LF), tautomycin and okadaic acid. Each sample (N = 4),
ran in triplicate with a substrate blank, is presented with standard error (SE). The trend in PP1 activity
inhibition by each toxin, as determined by the magnitude of the linear regression slope (LRS) of
the PPIA, is in agreement with previously published PP1 inhibitory constants (Ki ) [29]: MC-LR and
MC-LF have similar PP1 inhibition potencies with the steepest negative significant LRS, followed by
tautomycin and then okadaic acid.
Toxin

LRS

SE

p Value

PP1 Ki (µg/L)

Methanol
MC-LR
MC-LF
Tautomycin
Okadaic Acid

´0.359
´0.463
´0.550
´0.0542
´0.000919

1.29
0.0423
0.0402
0.00473
0.0000582

0.785
<0.0001
<0.0001
<0.0001
<0.0001

0.04
0.33
118

The optimized PPIA described here was able to differentiate between MC-LR, okadaic acid
and tautomycin based on a correlation between observed LRS and published PP1 Ki using purified
rabbit PP1 and pNPP [29]. These data confirm that the optimized PPIA responded appropriately to
pure toxins with different potencies for PP1 inhibition. Ranking the potencies from most potent to
least potent based on increasing concentrations needed to inhibit 20%–80% PP1 activity is as follows:
MC-LF > MC-LR > tautomycin > okadaic acid. Methanol did not significantly alter PP1 activity and
was therefore not included in this ranking. These data confirm the usefulness of the PPIA to detect a
variety of PP inhibitors that can be present in water samples. As okadaic acid is produced by marine
dinoflagellates [30] and tautomycin is produced by the bacterium Streptomyces spiroverticillatus found
in shellfish [31], it is unlikely either of these marine toxins would be in fresh water or surface drinking
water. In addition, it is important to reiterate that the PPIA with PP1 is capable of detecting any
compound that inhibits PP1, including those that may escape detection by current LC-MS/MS and/or
ELISA methods. Amongst potential freshwater cyanotoxins, the only other known toxin that can
inhibit PP1 is nodularin, a toxin primarily found outside of the US and in brackish water. There is
concern for nodularin to be present in water suitable for drinking in Australia [32,33].
We tested two MCs, MC-LR and MC-LF, as there is little known about the inhibition potency of
MC variants with different physicochemical properties. MC-LR and MC-LF were chosen based on
their estimated [34] and experimental [20] octanol-water partition coefficient, lethal concentration [20],
and recombinant PP1 IC50 [35]. In our study MC-LR and MC-LF inhibited PP1 with similar potency
suggesting that the difference in hydrophobicity did not influence the toxicodynamics in the PPIA.
This is in agreement with several published studies demonstrating that MC-LR and MC-LF have
similar IC50 values for PP1 (1.2 and 1.8 µg/L [36], 1 and 3µg/L [37], 1.4 and 2.2 µg/L [38], for MC-LR
and MC-LF, respectively). Recently a study using PP1 and pNPP to establish inhibition equivalency
factors for different MC congeners in relation to MC-LR determined an IC50 of 2.1 µg/L for MC-LR
and an IC50 of 359.3 µg/L for MC-LF [35]. The overall trend of lowest to highest IC50 was as follows:
MC-LR > MC-RR > MC-YR > MC-LY > MC-LW > MC-LF. The discrepancy in this observed trend in
IC50 s for different MCs and the previously mentioned studies that showed similar IC50 s may be a result
of the source and nature of the enzyme, or the concentrations and purity of the MC variant standards,
some of which were not certified in the study. Thus, it is critical that each laboratory establishes and
validates assay conditions to accurately interpret results.
For the validation of the PPIA and the subsequent statistical analyses we chose two different
congeners to represent the hydrophilic and hydrophobic characteristics of MCs. Once validated, one of
the major objectives for the optimized PPIA was to determine overall biological toxicity in minimally
processed environmental samples. To examine the PPIA toxicity data from two case studies further,
LC-MS/MS data were generated and compared to PPIA data. Available standards for LC-MS/MS
analysis included MC-LA (1.3/4.2 µg/L limit of detection (LOD)/limit of quantitation (LOQ)), MC-LR
(0.2/0.5 µg/L LOD/LOQ), MC-LF (1.9/6.4 µg/L LOD/LOQ), MC-RR (0.2/0.6 µg/L LOD/LOQ), and
MC-YR (0.3/0.7 µg/L LOD/LOQ).
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Case A: 2013
Kentucky
Casecattle died suddenly in or around two ponds on a farm in Nelson County,
KY, USA. Pond water from two ponds (A1 and A2) and rumen contents from three cattle (A3–A5)
In August 2013 fifteen cattle died suddenly in or around two ponds on a farm in Nelson
were collected. As part of a comprehensive diagnostic investigation of a high mortality event, pond
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Figure 2. Protein phosphatase inhibition assay (PPIA) of two pond water samples (samples A1 and

Figure 2. Protein phosphatase inhibition assay (PPIA) of two pond water samples (samples A1 and A2)
A2) and of rumen contents of three deceased cows (samples A3–A5) that had access to those ponds.
and of rumen contents of three deceased cows (samples A3–A5) that had access to those ponds. Control
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Table 2. Liquid chromatography-mass spectrometry (LC-MS/MS) and protein phosphatase inhibition
assay (PPIA) results of water samples A1 and A2 and rumen content samples A3–A5 collected from
a farm in Nelson County, Kentucky. Control rumen sample A6 was collected from a ruminating calf
without exposure to cyanotoxins. Results from the PPIA assay are described as a linear regression
slope (LRS), with corresponding standard error (SE) and p value. N.D. = not detected.
PPIA

A1
A2
A3
A4
A5
A6

Sample Type

LC-MS/MS (µg/L)

LRS

SE

p Value

Pond Water
Pond Water
Rumen Contents
Rumen Contents
Rumen Contents
Rumen Contents, Control

N.D.
LR 5.7
LR 1.3
LR 4.3
LR 1
N.D.

0.00419
´0.0364
´0.0211
´0.0867
´0.0166
´0.000120

0.000497
0.00536
0.00169
0.00420
0.00116
0.000629

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.851

This case investigation confirmed the usefulness of the PPIA with the linear regression model
to detect PP inhibitors in water and rumen content samples. The magnitude of negative LRS for
each rumen content sample correlated with the MC-LR level in each sample, suggesting that MC-LR
was the predominant toxic MC congener in pond A2. Direct comparison of the LRS between sample
types is not possible because pond water and rumen content samples are different matrices. To the
best of our knowledge, this is the first documented report of detecting PP1 inhibitors in rumen
content samples using the PPIA. The PPIA offered a number of advantages over LC-MS/MS analysis.
First, it was a rapid assay to obtain qualitative data about the presence of PP1 inhibitors. Second,
with the use of the LRS model no standard curves were required for each PPIA. Usually, MC-LR is
used as a standard to determine PP1 inhibitor concentration in terms of MC equivalents. While it
is possible to use up to ten standard concentrations to estimate the amount of PP1 inhibitor present
in a sample [27,35], quantitation is not necessary for these investigations and can be attempted with
LC-MS/MS as a follow-up. While canine deaths due to cyanotoxin exposure are more likely to be
reported, cattle may be at greater risk of cyanotoxin exposure due to their reliance on fresh water
drinking ponds. In the US, 24 of a herd of 175 Hereford X Angus heifers [39] and nine of a herd of
60 Holsteins [40] died after cyanotoxin exposure. Clinical signs included nervousness, recumbency,
weakness, anorexia, dehydration, ruminal atony and hypersensitivity to noise [39,40]. While there
are few recent publications reporting cattle deaths from cyanotoxin exposure in the US, there have
been several reports on public forums: 24 cattle died over three days in Burlington Colorado in July
1997 [39], four cows died due to cyanobacteria exposure from a pond near a ranch in Gwinnett County,
Georgia in June 2012 [41] and cattle deaths were attributed to cyanotoxins in Kansas in June 2012 [42].
These reports emphasize the susceptibility of cattle to cyanotoxins, the economic impact and the need
to carefully monitor water quality on ranches. Possible effects of sublethal cyanotoxin exposure on
cow performance and milk and meat quality are poorly understood. However, due to the covalent
binding of MCs to their targets, it is assumed that bound MCs are not biologically active. More data on
the toxicokinetics of different MC congeners in cattle are needed to understand possible tissue and
milk residues and the risk to consumers.
2.4. Case B: Clear Lake, California
A Labrador retriever developed lethargy, vomiting, diarrhea and inappetence after two days of
swimming in Clear Lake, CA, USA in August 2013. The dog was euthanized four days later due to
severe disseminated intravascular coagulopathy (DIC). One week after the dog swam in the lake, Lake
County Department of Water Resources collected and submitted water samples from near shore where
the dog had accessed the lake (sample B1). Visually, the water samples contained algae. Sample B1 had
detectable levels of MC-LA and MC-LR by LC-MS/MS analysis and significant potent PP1 inhibition
(p < 0.0001, Table 3, Figure 3). Three weeks later lake water from the same near-shore location (sample
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B2) and 200 feet from shore (sample B3) were submitted for analysis: MC-LA, MC-LR, MC-LF, and
MC‐LA,
and MC‐RR
were detected
shore and
MC‐LR,
MC‐LF,
MC-RR
were MC‐LR,
detectedMC‐LF,
near shore
and MC-LR,
MC-LF, near
and MC-RR
were
detected
200and
feetMC‐RR
from shore.
were
detected
200
feet
from
shore.
B2
and
B3
had
significant
inhibition
of
PP1
activity
(p
<
0.0001,
B2 and B3 had significant inhibition of PP1 activity (p < 0.0001, Table 3, Figure 3). The following week
Table 3, Figure 3). The following week a third near‐shore water sample was submitted (sample B4),
a third near-shore water sample was submitted (sample B4), and had low detectable levels of MC-LR,
and had low detectable levels of MC‐LR, MC‐LF, and MC‐RR and no significant PP1 inhibition (p =
MC-LF, and MC-RR and no significant PP1 inhibition (p = 0.0727 Table 3, Figure 3). Samples from the
0.0727 Table 3, Figure 3). Samples from the dog were not available for testing.
dog were not available for testing.
Table 3. Liquid chromatography‐mass spectrometry (LC‐MS/MS) and protein phosphatase
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slope
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with
corresponding
standard
error
(SE)
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as
value.
a linear regression slope (LRS), with corresponding standard error (SE) and p value.
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Figure 3. Protein phosphatase inhibition assay (PPIA) of water samples collected from Clear Lake,
Figure
3. Protein phosphatase inhibition assay (PPIA) of water samples collected from Clear Lake,
California in response to a dog’s death after swimming in the lake. One week after the dog swam in
California in response to a dog’s death after swimming in the lake. One week after the dog swam in
the lake sample B1 was collected near shore, close to the location where the dog swam. Samples B2
the lake sample B1 was collected near shore, close to the location where the dog swam. Samples B2 and
and B3 were collected three weeks after the first sampling; sample B2 from near shore and sample B3
B3 were
collected three weeks after the first sampling; sample B2 from near shore and sample B3 200
200 feet from shore. Sample B4 was collected near shore four weeks after the first sampling. Each
feet from
Sample
was collected
near shore
fouris weeks
after the
firstpoint.
sampling.
Each
Relative
PP1PPIA
PPIAshore.
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ran in B4
triplicate
with a substrate
blank,
represented
as one
(N = 4),
ran inrate
triplicate
a substrate
is represented
one point.PP1
Relative
PP1
activity
activity
(y‐axis),with
measured
as logblank,
(exposed
PP1 activity as
rate/control
activity
rate),
was rate
(y-axis),
measured
as logregression
(exposedmodel
PP1 activity
rate/control
activityinterval
rate), was
analyzed
as a linear
analyzed
as a linear
(black line)
with a 95%PP1
confidence
(shaded
gray area).
X‐axismodel
represents
the line)
volume
of processed
environmental
sample
added
to the
PPIA.
regression
(black
with
a 95% confidence
interval
(shaded
gray
area).
X-axis represents the
volume of processed environmental sample added to the PPIA.
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The PPIA results of Clear Lake water samples confirm the presence of toxins capable of inhibiting
PP1 one week after the dog’s sudden illness. In mammals, PP1 inhibition can result in extensive loss of
hepatic architecture, hepatocyte necrosis and hepatic hemorrhage [43]. The dog’s rapid decline from
nonspecific clinical signs to severe DIC in four days is likely the result of acute hepatic necrosis, which,
combined with a history of swimming in a lake known to contain cyanobacteria [44] suggests MC
toxicosis as the most likely cause of death. Furthermore, exposure to α-amanitin, a potent hepatotoxin
in Amanita spp. mushrooms present in the Clear Lake area, was ruled out by a negative result of urine
analysis. Leptospirosis, an important differential diagnosis due to the hemorrhagic presentation, was
ruled out by post-mortem diagnostic testing.
The LRS of the PPIA model became less negative over the course of several weeks of sample
collection, suggesting that the overall biological toxicity of the Clear Lake samples decreased over
time. In agreement with the biological assay, the concentrations of each detected MC congener
decreased over the month long sampling period. Interestingly, the congener composition also changed.
MC-LA was only detected near shore in weeks one and four while MC-LR was detected in all
collected water samples. MC-LF and MC-RR were detected in near and far shore samples in weeks
four and five. MC-LR concentrations increased between weeks one and four, before decreasing
to below week one concentrations in week five, suggesting a dynamic environment of cyanotoxin
production and degradation during the month of August. The appearance of detectable concentrations
of MC-LF and MC-RR and disappearance of MC-LA also support the idea of a dynamic and complex
lake water environment, emphasizing the need to collect water samples quickly after a toxicosis
event and regularly at various locations to detect potential health risks. The appearance of high
concentrations of MC-LF was surprising and demonstrates the necessity to expand the list of traditional
MC congeners (MC-LR, MC-RR, MC-YR and MC-LA) in monitoring efforts. MC-LF is considered
hydrophobic [45] and has the potential to bind sediment, which, if disturbed, may result in MC release
even without a concurrent bloom and further complicate diagnostic investigations and public health
monitoring efforts.
With highly variable MC congener concentrations detected over the four-week period, the PPIA
is a useful tool to detect PP1 inhibitors in dynamic cyanobacterial ecosystems. Chemical detection may
underestimate MC concentrations and misjudge the risk of cyanotoxins. The first sample (B1) had the
most potent PP1 inhibition, but did not contain the highest detected concentrations of MCs. Additional
MC congeners not detectable by the LC-MS/MS method may have been present. Sample matrix
composition appears to influence PPIA results with the potential to increase PP1 activity. Sample B4
had low detectable concentrations of MCs by LC-MS/MS but a positive PPIA linear slope. This finding
suggests that the water contained compounds that were capable of catalyzing the formation of pNP by
PP1, which was also observed in the sample A1 from the Kentucky case. It is possible that many water
samples contain PP1 catalysts capable of the formation of pNP. Only water samples with sufficient MC
concentrations to inhibit PP1 activity greater than the catalyst’s ability to produce pNP will result in
significant negative linear slopes. This limitation is important to consider in the future use of the PPIA
with environmental samples. Minimal environmental sample processing used in this study may play a
role; therefore, additional cleanup procedures may reduce this problem but will require more time
and costs. Our case investigation showed that the use of the PPIA with the linear regression model is
suitable for identifying potent toxins that may escape detection by LC-MS/MS.
MCs can persist in natural waters in the dark for months or years, yet can undergo slow
photochemical breakdown and isomerization in full sunlight, with over 90% breakdown in
two–six weeks, depending on the presence of pigments and humic substances [46]. In this study,
PP1 inhibitory activities decreased over the span of one month while individual MC congener
concentrations increased and decreased over time. A combination of removal pathways, such as
UV and bacterial degradation, dilution and dispersion throughout the lake, and/or bioaccumulation
in fish and other organic matter may have played a role in the decreasing concentrations.
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Samples from the dog were not available for testing to confirm the presence of cyanotoxins in the
gastrointestinal tract or tissue samples. Historical data and regular water testing of Clear Lake have
confirmed the presence of cyanotoxins for many years, and this provides a reasonable basis for our
conclusion that the dog likely consumed a lethal dose of MCs. In particular, a few weeks before the
dog’s death, concern over visible cyanobacterial blooms triggered the Lake County Department of
Water Resources to collect water samples from three different locations for cyanobacteria identification
by a phycologist (Green Water Laboratories, Palatka, FL, USA). Clear Lake Lower Arm, near the
area of the dog’s lake access, contained Woronichinia naegeliana while Clear Lake Park contained
Microcystis panniformis, Woronichinia naegeliana, Microcystis wesenbergii and Microcystis botrys and Clear
Lake Upper Arm contained Aphanizomenon cf flos-aquae, Gloeotrichia echinulata, Anabaena sp. and
Woronichinia naegeliana. These cyanobacteria were identified in Clear Lake previously during the
summer months [44] and Microcystis spp., Anabaena spp. and Gloeotrichia spp. are all producers of
MCs. Additionally, Clear Lake data from 2011 show highest MC concentrations between August and
October in all areas of the lake. Based on all information available, it is very plausible that the dog
died from MC toxicosis. To the best of the authors’ knowledge, this is the first known canine death
from consuming harmful cyanobacteria toxins from Clear Lake [47]; the last report of known canine
illness from cyanobacteria consumption from Clear Lake is from the late 1920s [48].
Apart from Clear Lake, other water sources in California have resulted in animal deaths with
most reports from Northern California. Three dogs died in Castro Valley, five dogs died in Big Lagoon
in 2001, and four dog deaths occurred after swimming in the South Fork of the Eel River in 2002 and
2004 [49,50]. In the US, between the late 1920s and 2012, an estimated 368 dogs died or developed
illness after exposure to cyanotoxins [51]. In recent years, the continued and increasing risk for
cyanotoxin exposure is illustrated by six dogs dying in 2014 and three in 2015 after swimming in or
drinking cyanobacterial bloom-contaminated water [52–56]. The frequency of cyanotoxin exposure in
animals is likely underreported due to the indiscriminant behavior of animals and absent diagnostic
investigations. Beyond the US, the hazard of cyanotoxins is a global concern since the first report
of cyanobacterial toxicosis of animals in 1878 from Australia [57], and with massive cyanotoxin
blooms continuously reported from all over the world, including Lake Taihu, China [58] and Lake Erie,
Ohio [59]. The PPIA with a linear regression model presented here ensures that the effects of potentially
toxic PP inhibitors are accounted for and considered in veterinary diagnostic investigations. Valuable
other assays to consider in investigations include ELISA, HPLC, and metagenomics; methodology
details are beyond the scope of this publication. Most of these methods require a higher level of
technical skill and advanced resources compared to the PPIA used here. The PPIA is a cost-effective
and statistically sound method that should be used in parallel with LC-MS/MS analysis during
cyanotoxins exposure investigations.
3. Experimental Section
3.1. Chemicals and Reagents
MC-LR was purchased from Sigma-Aldrich (St. Louis, MO, USA, discontinued) and MC-LR,
MC-RR, MC-YR, MC-LA and MC-LF were purchased from Enzo Life Sciences (Farmingdale, NY, USA,
1 mg, purity of ě95% (HPLC)). Okadaic acid was purchased from LC Laboratories (Woburn, MA, USA,
100 µg, purity 98%) and tautomycin was purchased from AG Scientific, Inc. (San Diego, CA, USA,
discontinued, 100 µg, purity 97%) and Wako Chemicals (Richmond, VA, USA, 100 µg purity ě90%).
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) at analytical grade or higher.
MC-LR, MC-LF, okadaic acid and tautomycin were dissolved in 1 mL of 2.5% methanol and stored at
´20 ˝ C at final stock concentrations of 1,000,000 µg/L (MC-LR), and 100,000 µg/L (MC-LF, okadaic
acid, tautomycin). Recombinant PP1 was purchased from EMD Millipore (Billericia, MA, USA, 100 U,
2500 U/mL, α-isoform, rabbit muscle, recombinant, E. coli). Stock PP1 was solubilized in storage buffer
according to manufacturer (200 mM sodium chloride, 50 mM HEPES, 2.5 mM dithiothreitol (DTT),
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1 mM manganese chloride (MnCl2 ), 0.1 mM ethylene glycol tetraacetic acid (EGTA), 50% glycerol,
0.025% TWEEN-20 detergent, pH 7) to a final concentration of 250 U/mL; aliquots of 40 µL were stored
at ´80 ˝ C.
3.2. Sample Collection and Preparation
Water samples from Clear Lake, California, and Nelson County, Kentucky, were collected in
1 L amber glass bottles, shipped overnight to the University of California, Davis, and stored at 4 ˝ C
until further processing. Rumen samples were collected during necropsy at the Veterinary Diagnostic
Laboratory, University of Kentucky, Lexington, KY, USA. For sonication, 10 mL of homogeneous water
sample or liquid from rumen contents were sonicated using the Microson™ XL 2000 Ultrasonic liquid
processor (probe model CML = 4, Newton, CT, USA) at 50% output on ice for 10 min. Samples were
then centrifuged for 10 min at 4500 RCF. Supernatant was removed, spun again if sample had high
turbidity; aliquots of 1.5 mL were stored at ´20 ˝ C.
3.3. Liquid Chromatography Mass Spectrometry/Mass Spectrometry
An aliquot of 500 µL of homogenous samples was filtered through a 0.2 µm Nylon membrane
(EMD Millipore, Billericia, MA, USA) by 10,000 g force for 10 min in centrifuge tubes. A 10 µL sample
was injected on to a ACQUITY UPLC BEH C18 column (Milford, MA, USA) (130 Å pore size, 1.7 µm
particle size, 2.1 mm ˆ 50 mm) for chromatographic separation. LC-MS/MS analysis was performed
on an EVOQ (Bruker, Fremont, CA, USA) system. The mobile phase was (A) water containing 0.1%
formic acid (v/v) and (B) methanol containing 0.1% formic acid (v/v). The column was eluted with
150 µL/min mobile phase. The 10 minute elution began with 50% B, then gradually increased to 90%
B over 6 min, held at 90% B for 2 min, then changed back to 50% B within 1 minute and balanced for
the last 1 minute.
The mass spectrometer was set to heated positive electrospray ionization (HESI) mode with
spray voltage 4.5 Kv, cone temperature 300 ˝ C, cone gas flow 15 A.U. (arbitrary unit), heated
probe temperature 350 ˝ C, probe gas flow 30 au and nebulizer gas flow 30 A.U. The LC-MS/MS
characteristics of each microcystin congener are listed in Table 4. The LODs were determined based
on the signal-to-noise ratio of 3:1, while the LOQs were calculated from the signal-to-noise ratio of
10 times the noise level. For concentrations below the LOQ but above the LOD, we used estimated
values provided by the LC-MS/MS analysis software, Bruker MSWS 8.0.1 (Bruker, Billerica, MA, USA).
Values below the LOD were reported as not detected.
Table 4. Liquid chromatography-mass spectrometry characteristics of microcystins (MC) isomers
including the limit of detection (LOD) and limit of quantification (LOQ).
ID

Molecular
Weight (Da)

LOD/LOQ
(µg/L)

Retention
Time (min)

Precursor
Ion

Product Ion

Collision
Energy

MC-RR

1038.2

0.2/0.6

3.19

519.7

135.0

34

MC-YR

1045.2

0.3/0.7

3.95

523.6
523.6
523.6

135.6
507.8
456.7

30
30
30

MC-LR

995.2

0.2/0.5

4.30

498.4
498.4
498.4

135.1
430.5
482.1

20
20
10

MC-LA

910.0

1.3/4.2

6.70

910.0
910.0
455.5

372.8
399.5
172.4

30
30
60

MC-LF

986.2

1.9/6.4

7.63

1008.0
1008.0

510.5
504.2

74
73
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3.4. Protein Phosphatase Inhibition Assay
Enzyme solution buffer (52 mM Tris-HCl (pH 7.0), 0.12 mM EGTA, 1 mM DTT (DTT in 0.01 M
sodium acetate, pH 5.2), 2 mM MnCl2 , 0.5 mg/mL bovine serum albumin (BSA)) and reaction buffer
(62.5 mM M Tris-HCl (pH 8.1), 0.2 mM MnCl2 , 26 mM magnesium chloride, 0.5 mg/mL BSA, 2 mM
DTT) were freshly prepared and kept on ice.
For the 96-well plate colorimetric assay, rows A and H and columns 1 and 12 were not used
due to previously reported temperature differences in those wells [60]. All wells contained a final
volume of 250 µL. Plate blanks were five wells per plate containing reaction buffer. To optimize the
assay, 10 µL of MC-LR or MC-LF (0, 0.125, 0.25, 0.5, 1 µg/L), tautomycin (0, 1.6, 3.3, 6.5, 13 µg/L) or
okadaic acid (0, 100, 250, 375, 500 µg/L) were added to wells in triplicate (dilutions in reaction buffer
prepared fresh for each assay). Twenty microliters PP1 (working solution diluted in enzyme buffer,
final well concentration 0.5 U/mL) and 220 µL pNPP (working solution made with reaction buffer,
final well concentration 100 mM) were added to initiate the colorimetric reaction. Substrate blanks
were prepared in duplicate, and contained pNPP (final well concentration 100 mM). The negative assay
plate control, with no toxin, represented the baseline PP1 activity for that plate, which was compared
to each toxin exposed PP1 activity rate to determine if exposure to MC-LR, MC-LF, okadaic acid or
tautomycin changed PP1 activity.
To run prepared environmental samples, the same method was followed as above (250 µL total
final volume and 20 µL PP1), except 0, 2.5, 5, 10 or 20 µL of sample was added to wells in triplicate
(final well concentrations 0%, 1%, 2%, 4%, or 8% of prepared sample, diluted in reaction buffer as
needed) and 210 µL pNPP (final well concentration 100 mM) was added to initiate the colorimetric
reaction. Substrate blanks contained 0, 2.5, 5, 10 or 20 µL of sample and pNPP (final well concentration
100 mM) to correct for sample pigment coloration and pNPP hydrolysis by the sample itself. PP1 with
and without MC-LR were included as positive and negative assay plate controls to make sure PP1
inhibition could occur successfully if MCs were present. The negative assay plate control, with no
MC-LR or sample extract, also represented the baseline PP1 activity for that plate, which was compared
to each exposed PP1 rate, to determine if exposure to a sample changed PP1 activity.
Well ocular density (OD) readings were measured using a spectrophotometer (Molecular Devices
SpectraMax M3, Sunnyvale, CA, USA) and recorded (SoftMax Pro software version 5.4, Molecular
Devices Corporation, Sunnyvale, CA, USA) at 405 nm and 37 ˝ C, every two minutes for 1.5 h. The rate
of PP1 activity was measured as millimoles of pNPP hydrolyzed to pNP per nanogram PP1 per minute
(mM p-NP produced/ng PP1/min). A linear rate was required for data interpretation; therefore the
rate between 1000–5400 s was used for analysis. The rate between 0–1000 s for the substrate blank
and samples were similar, while after 1000 s the substrate blank rate would plateau while the PP1
rate would continue to increase. Rate of hydrolysis was determined using Beer’s Law: C = A/(εl),
where C = concentration of pNP, A = absorbance measured over time (OD/min), ε = 18,000 M´1 ¨ cm´1
(extinction coefficient for pNP) and L = 0.848 cm (pathlength for 250 µL for the 96-well plate, determined
using potassium chromate at 405 nM, ε = 1355 M´1 ¨ cm´1 ). Plate blanks were subtracted from all
pNPP hydrolysis rates. Average substrate blank hydrolysis rates were subtracted from the average
enzymatic hydrolysis rates and then divided by the amount of PP1 used (1.563 ng). Each sample was
tested in triplicate at least four times on different plates.
3.5. Statistical Analysis
Due to plate-to-plate variation, the exposed rate of PP1 activity was compared to baseline PP1
activity for that given plate, which had no toxin or sample included. Therefore, each data point
presented is a ratio of the exposed PP1 rate over the baseline PP1 rate, i.e., the change in PP1 activity
when a given volume of toxin or sample is added to the reaction. The data were transformed by
specifying the response variable as the relative activity change, measured as log (exposed PP1 activity
rate/control PP1 activity rate). This allowed data to be analyzed with a linear regression to determine
if there was a significant change in PP1 activity with increased toxin concentration or sample volume.
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Standard error of the data (N = 4 for all samples) is presented in the tables with the linear regression
slopes. Data were grouped by toxin or sample and analyzed using a linear regression. Graphs represent
the log (exposed PP1 activity rate/control PP1 activity rate) on the y-axis and the concentration of toxin
or volume of prepared sample tested on the x-axis. The maximum likelihood model is represented on
the graph as a black line with a 95% confidence interval (R program, ggplot2 [61]). Significance was
attributed to p < 0.05.
4. Conclusions
Biological toxicity assays and quantitative MC analyses play critical roles in the diagnostic
investigations of suspect cyanotoxin exposures. The PPIA with a linear regression analysis can
effectively detect naturally occurring PP1 inhibitors. The method can differentiate between purified
MCs, okadaic acid and tautomycin in agreement with previously published inhibitory constants.
The functional toxicity assay serves an important purpose when evaluating samples for PP1 inhibitors
that escape analytical detection. This approach ensures that the effects of potentially toxic yet
non-tested MC congeners are accounted for and considered in veterinary diagnostic investigations.
Both veterinary cases demonstrate that with minimal sample preparation it is possible to have
potentially catalytic compounds, which in one case resulted in false negative PPIA data for MCs.
Despite this limitation, our case investigation was greatly enhanced with the use of the PPIA. It is
expected that the use of functional assays will play an increasingly important role in the diagnostic
investigation of PP inhibitors in biological and water specimens.
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